Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. - Test2 - elhamkhani - TriplyDB

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

http://www.wikidata.org/entity/Q34164063

about

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study Interleukin-28B genotype testing to determine response to the combination of pegylated-interferon and ribavirin for the treatment of hepatitis C virus IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study.Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.Dynamics of HCV RNA levels during acute hepatitis C virus infection.Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.Characterization of the Interleukin-28B Gene rs12979860 C/T Polymorphism in Turkish Chronic Hepatitis C Patients and Healthy Individuals.The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C.Role of genetic polymorphisms in hepatitis C virus chronic infection.The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.Two IL28B polymorphisms are associated with the treatment response of different genotypes of hepatitis C in different racial populations: A meta-analysis.Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.The natural killer cell response to HCV infection.Impact of Interleukin 28B Genotype on the Virological Responses in Chronic Hepatitis C Treatment.Role of interleukin-28B genetic polymorphisms in Korean patients with hepatitis C virus infection.Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making Hepatobiliary quiz-3 (2012)

P2860

Q28477975-EA56C266-114B-4620-83C9-DAEB55DC4C60 Q30365599-FDF8ADA1-4F1D-48DC-AE6B-2F1A84614E96 Q33779801-98638AE2-7FBA-47AB-A830-318A0C081D72 Q33807010-8F71E268-3CCC-4D1A-BAD9-FBBFBA5095F1 Q33867243-9190113F-74DC-4109-A60B-EAF0A75FE58A Q34008754-371E9D63-6D3A-4B7D-B6CD-465C1C78DB7B Q34411907-98C988F5-9296-4364-A806-24EBD1F025F0 Q34539324-38899E47-3F3A-4550-9820-F8924AE0716E Q34546135-63B51B51-DB9D-4832-8174-D8D40FCEAA18 Q34714349-F98F8298-DB1B-4131-9474-D85202A8E502 Q34771346-290D3542-76B3-4233-B921-CC8720AB81B6 Q34785317-5053CCB4-E0B1-42E1-AAC7-C0D74CBE38F0 Q35053399-EE853D83-9A67-4601-8CA7-F7982A0784BE Q35065912-78E34A5A-155A-455F-AA9D-BF5BF324FF2E Q35083980-903C9AAA-BB5F-4E68-A567-C04666D6CFB1 Q35249648-15F3D2BD-43AD-47A1-9EB6-4CC9D5D2F158 Q35381792-3DE70042-0F9B-463D-9198-6B97D029AC1A Q35609162-8443C3B6-265D-41B7-8EBA-50E9F865612B Q35764210-5BEAEBAF-1035-44F5-A057-35D9C2B53268 Q35779058-71681E8A-A15D-412E-8010-DBCC70F668F7 Q35812034-779A2A1B-FA95-4BD3-BECD-2B2078040509 Q35832850-27FBE4A9-5632-4DA8-86F8-CB5A007D7C5E Q35925546-2398C750-2914-4DB7-8FC6-4181A9DDF8C7 Q35930570-9285DA03-B32F-41F3-9B3E-B768DC110B87 Q36013021-6B171540-9DC7-42FC-90CA-7D3A51F710E5 Q36148971-40B47621-4A13-4432-818D-8449187EE670 Q36200292-A3833FD7-2067-487C-9D03-5CAF8A46F51C Q36224697-29D62A99-5A61-44BD-B3BD-609A39E6DEE4 Q36330949-1DC00E65-3B77-4865-B11E-E9DB708E6968 Q36478562-371AF06D-305B-4C1A-87AF-D019EFA7AA55 Q36670894-CE2432EE-8B69-4DCB-B2C6-F4B843D5BD51 Q36717008-E9CA5B91-F689-4443-AA72-1548EDF8FBFE Q36874661-42AECBC5-809B-4853-893D-C35E06466DB2 Q37130266-6342EC3C-12FC-4D41-B039-4449284FA489 Q37255644-87EB598F-A80F-4A22-A82C-5C3350703F4F Q37279158-7F436E8F-74E5-4944-9945-BA99427A0BD9 Q37292899-E19B7F93-6F25-4A4A-8CFE-CAF4EF6BC2DA Q37564055-A88288CE-ADE4-436D-9801-1B1001F7E930 Q37613481-060B8185-AEB9-467F-8BD7-B858D855B142 Q37613918-246A372D-7CBF-4A14-981A-A57F45AA6D93

P2860

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

http://www.wikidata.org/entity/Q34164063

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Potential role for interleukin ...... t hepatitis C virus infection.

@ast

Potential role for interleukin ...... t hepatitis C virus infection.

@en

Potential role for interleukin ...... t hepatitis C virus infection.

@nl

type

label

Potential role for interleukin ...... t hepatitis C virus infection.

@ast

Potential role for interleukin ...... t hepatitis C virus infection.

@en

Potential role for interleukin ...... t hepatitis C virus infection.

@nl

prefLabel

Potential role for interleukin ...... t hepatitis C virus infection.

@ast

Potential role for interleukin ...... t hepatitis C virus infection.

@en

Potential role for interleukin ...... t hepatitis C virus infection.

@nl

P1433

Q34164063-4A0F954B-B321-496E-A310-8A371B2AF9A3

P1476

Q34164063-162684D8-940B-4DBD-ABC9-B463944EB1F0

P2093

Q34164063-0AB16812-907B-4190-A757-B050A410F122

Q34164063-17BA0F77-3A20-4DB2-99B3-533CACB3533E

Q34164063-1A1BA3BC-DB52-4286-AB55-99EC44B4D25B

Q34164063-28C267A2-7333-4A63-A1F5-22B07050C8C3

Q34164063-50BDFC19-F020-443A-9AFA-895239CB302E

Q34164063-53C7FC99-FD44-40CC-9F72-712A7C151F53

Q34164063-56577EDB-9FAF-4A9F-BD32-7367236E673F

Q34164063-575F45FB-379E-4202-82C2-83281F4026CD

Q34164063-6B793C4D-2BA4-4971-B688-B32EE378C38C

Q34164063-7906967F-CA62-4194-B5D8-AECA9032A1C9

P2860

Q34164063-0D40F6C8-1647-42BF-BA85-F5303D86B426

Q34164063-174C922F-FEA6-41BC-9999-9EC3A942441D

Q34164063-1CB90B0D-970E-4F00-9DA0-E556074088FB

Q34164063-1DA8D588-5767-4287-A6C4-D35ABFDE92C4

Q34164063-37BF69E2-57F2-4C42-B6E2-BB5654BBFA78

Q34164063-3CE163B9-31EC-4995-809D-CD51F7D15E4E

Q34164063-3D4E0BA9-45FB-47AE-B2F8-A75C3234F2C7

Q34164063-4C10E9AF-F272-4376-93AC-1D0B6D6D3CBC

Q34164063-4C98DC90-9B1B-45A5-9FA0-3F9B69ADEBC3

Q34164063-4CF66494-9294-48BD-9E20-92AF44DD9F71

P304

Q34164063-D0394A61-6282-40F5-98FE-9B2FD3FC843B

P31

Q34164063-8009FB55-CB2A-42C0-BCA9-A255AB252EC8

P356

Q34164063-91EF7347-CD99-4CC7-8449-43E54AC25DEA

P407

Q34164063-26D07B0D-428F-4BC8-A0FE-576D378DA147

P433

Q34164063-55EA6280-B8CB-4824-892D-BF06A1F9EE5E

P478

Q34164063-EE71E469-A280-41CB-99C7-5BBA4AA4F629

P50

Q34164063-13D381CD-D221-4FC1-8681-CAAF0865B2FA

Q34164063-8E38A2C8-8F90-4E2E-860A-B7DC55E67A11

Q34164063-D6E7DCEA-BDB8-4212-A59F-DE36FE2334E8

P577

Q34164063-57273B21-5C40-4521-8EB2-4EE7D8892633

P5875

Q34164063-7BF9C51D-FE6F-4EB8-B589-788E98C39906

P698

Q34164063-A3E395B3-986A-4F35-A0CD-589578E3C256

P921

Q34164063-b5a42425-0834-4421-9226-a254129f1d2c

P932

Q34164063-8B60ED5D-A5C0-4D0B-9108-47A17C669859

P356

P1433

P1476

Potential role for interleukin ...... t hepatitis C virus infection.

@en

P2093

ATAHC Study Group

http://www.w3.org/2001/XMLSchema#string

Barbara Yeung

http://www.w3.org/2001/XMLSchema#string

David Booth

http://www.w3.org/2001/XMLSchema#string

Gail V Matthews

http://www.w3.org/2001/XMLSchema#string

Gregory J Dore

http://www.w3.org/2001/XMLSchema#string

Jacob George

http://www.w3.org/2001/XMLSchema#string

Jason Grebely

http://www.w3.org/2001/XMLSchema#string

John M Kaldor

http://www.w3.org/2001/XMLSchema#string

Kathy Petoumenos

http://www.w3.org/2001/XMLSchema#string

Margaret Hellard

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Acute hepatitis C virus infection: A chronic problem

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

Haploview: analysis and visualization of LD and haplotype maps

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

P304

1216-1224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23850

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

William D. Rawlinson

Andrew R. Lloyd

Tanya Applegate

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46037856

http://www.w3.org/2001/XMLSchema#string

P698

20803561

http://www.w3.org/2001/XMLSchema#string

P921

P932

2947598

http://www.w3.org/2001/XMLSchema#string